CAS RN: 1258327-06-8

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis([1,1′-biphenyl]-4-yl)-diindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin-5-oxide

Product Availability

Choose a grade to view its available package options.

5 package records2 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260303 100mg In stock Shanghai Inquiry
Batchno.20250823 1g Out of stock Inquiry
Batchno.20250104 250mg Out of stock Inquiry
Batchno.20251129 50mg In stock Shanghai Inquiry
Batchno.20260114 5g Out of stock Inquiry
  • Product code: starshine_CAS1258327-06-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1258327-06-8 / 12-hydroxy-1,10-bis(4-phenylphenyl)-4,5,6,7-tetrahydroiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide

Standard CAS: 1258327-06-8 Multi CAS: No

Basic Information

CAS
1258327-06-8
Multi CAS
No
Molecular Formula
C41H31O4P
Molecular Weight
618.700000
Exact Mass
618.195996
SMILES
C1CC23CCC4=C2C(=C(C=C4)C5=CC=C(C=C5)C6=CC=CC=C6)OP(=O)(OC7=C(C=CC1=C37)C8=CC=C(C=C8)C9=CC=CC=C9)O
InChI
InChI=1S/C41H31O4P/c42-46(43)44-39-35(31-15-11-29(12-16-31)27-7-3-1-4-8-27)21-19-33-23-25-41(37(33)39)26-24-34-20-22-36(40(45-46)38(34)41)32-17-13-30(14-18-32)28-9-5-2-6-10-28/h1-22H,23-26H2,(H,42,43)
InChIKey
GKIAGFOQUKNWCU-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
46
Aromatic heavy atom count
36
Fraction Csp3
0.12
Rotatable bonds
4
H-bond acceptors
3
H-bond donors
1
Molar refractivity
183.13
TPSA
55.76

LogP / Solubility

WLOGP
10.4
MLOGP
9.21
XLogP3
10.1
Consensus LogP
9.9
Log S (ESOL)
-10.55
Class (ESOL)
Insoluble
Log S (Ali)
-12.15
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-12.8
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
0.89

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8

Get In Touch

Contact Us